Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma
- 1 June 2004
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 30 (5) , 544-550
- https://doi.org/10.1016/j.ejso.2004.03.007
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prospective Comparison of Endoscopy, Endosonography and Computed Tomography for Staging of Tumours of the Oesophagus and Gastric CardiaDigestion, 2002
- Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal CarcinomaJournal of Clinical Oncology, 2000
- Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patientsCancer, 2000
- Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinomaCancer, 1999
- Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapyCancer, 1999
- FDG uptake, tumour characteristics and response to therapyNuclear Medicine Communications, 1998
- BIOLOGY OF ESOPHAGEAL CANCER AND THE ROLE OF COMBINED MODALITY THERAPYSurgical Clinics of North America, 1997
- Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the EsophagusNew England Journal of Medicine, 1997
- A Comparison of Multimodal Therapy and Surgery for Esophageal AdenocarcinomaNew England Journal of Medicine, 1996
- Multimodality therapy for adenocarcinoma of the esophagusThe Annals of Thoracic Surgery, 1995